Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study
Tingting Bai,Enxin Wang,Shoujie Zhao,Dandan Han,Yan Zhao,Hui Chen,Jun Zhu,Tenghui Han,Yang Bai,Yanju Lou,Yongchao Zhang,Man Yang,Luo Zuo,Jiahao Fan,Xing Chen,Jia Jia,Wenbin Wu,Weirong Ren,Yejing Zhu,Shouzheng Ma,Fenghua Xu,Yuxin Tang,Xilin Du,Junlong Zhao,Jing Li,Xingshun Qi,Ying Han,Dongfeng Chen,Lei Liu
DOI: https://doi.org/10.3389/fonc.2023.1170923
IF: 4.7
2023-06-26
Frontiers in Oncology
Abstract:Background Advanced hepatocellular carcinoma (HCC) is characterized as symptomatic tumors [performance status (PS) score of 1-2], vascular invasion and extrahepatic spread, but patients with PS1 alone may be eliminated from this stage. Although liver resection is used for liver-confined HCC, its role in patients with PS1 alone remains controversial. Therefore, we aimed to explore its application in such patients and identify potential candidates. Methods Eligible liver-confined HCC patients undergoing liver resection were retrospectively screened in 15 Chinese tertiary hospitals, with limited tumor burden, liver function and PS scores. Cox-regression survival analysis was used to investigate the prognostic factors and develop a risk-scoring system, according to which patients were substratified using fitting curves and the predictive values of PS were explored in each stratification. Results From January 2010 to October 2021, 1535 consecutive patients were selected. In the whole cohort, PS, AFP, tumor size and albumin were correlated with survival (adjusted P<0.05), based on which risk scores of every patient were calculated and ranged from 0 to 18. Fitting curve analysis demonstrated that the prognostic abilities of PS varied with risk scores and that the patients should be divided into three risk stratifications. Importantly, in the low-risk stratification, PS lost its prognostic value, and patients with PS1 alone achieved a satisfactory 5-year survival rate of 78.0%, which was comparable with that PS0 patients (84.6%). Conclusion Selected patients with PS1 alone and an ideal baseline condition may benefit from liver resection and may migrate forward to BCLC stage A.
oncology